Skip to main content
Erschienen in: Strahlentherapie und Onkologie 10/2020

03.06.2020 | Review Article

Radiomic biomarkers for head and neck squamous cell carcinoma

verfasst von: Stephanie Tanadini-Lang, Panagiotis Balermpas, Matthias Guckenberger, Matea Pavic, Oliver Riesterer, Diem Vuong, Marta Bogowicz

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Tumor heterogeneity is a well-known prognostic factor in head and neck squamous cell carcinoma (HNSCC). A major limitation of tissue- and blood-derived tumor markers is the lack of spatial resolution to image tumor heterogeneity. Tissue markers derived from tumor biopsies usually represent only a small tumor subregion at a single timepoint and are therefore often not representative of the tumors’ biology or the biological alterations during and after treatment. Similarly, liquid biopsies give an overall picture of the tumors’ secreted factors but completely lack any spatial resolution. Radiomics has the potential to give complete three-dimensional information about the tumor. We conducted a comprehensive literature search to assess the correlation of radiomics to tumor biology and treatment outcome in HNSCC and to assess current limitations of the radiomic biomarkers. In total, 25 studies that explored the ability of radiomics to predict tumor biology and phenotype in HNSCC and 28 studies that explored radiomics to predict post-treatment events were identified. Out of these 53 studies, only three failed to show a significant correlation. The major technical challenges are currently artifacts due to metal implants, non-standardized contrast injection, and delineation uncertainties. All studies to date were retrospective and none of the above-mentioned radiomics signatures have been validated in an independent cohort using an independent software implementation, which shows that transferability due to the numerous technical challenges is currently a major limitation. However, radiomics is a very young field and these studies hopefully pave the way for clinical implementation of radiomics for HNSCC in the future.
Literatur
1.
Zurück zum Zitat Simard EP, Torre LA, Jemal A (2014) International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 50:387–403PubMedCrossRef Simard EP, Torre LA, Jemal A (2014) International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 50:387–403PubMedCrossRef
2.
Zurück zum Zitat Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446PubMedPubMedCentralCrossRef Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L, Group EW (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE‑5 population-based study. Eur J Cancer 51:2130–2143PubMedCrossRef Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L, Group EW (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE‑5 population-based study. Eur J Cancer 51:2130–2143PubMedCrossRef
4.
Zurück zum Zitat Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortes ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160PubMedPubMedCentralCrossRef Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortes ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160PubMedPubMedCentralCrossRef
5.
6.
Zurück zum Zitat Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110:803–811PubMedPubMedCentralCrossRef Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110:803–811PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedPubMedCentralCrossRef Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–163PubMedCrossRef Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–163PubMedCrossRef
9.
Zurück zum Zitat Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201PubMedCrossRef Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201PubMedCrossRef
10.
Zurück zum Zitat Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J, PET-NECK Trial Management Group (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444–1454PubMedCrossRef Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J, PET-NECK Trial Management Group (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444–1454PubMedCrossRef
11.
Zurück zum Zitat Combes JD, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50:370–379PubMedCrossRef Combes JD, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50:370–379PubMedCrossRef
12.
Zurück zum Zitat Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 18:40PubMedCrossRef Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 18:40PubMedCrossRef
13.
Zurück zum Zitat Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32:3365–3373PubMedPubMedCentralCrossRef Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32:3365–3373PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rodel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, von Neubeck C, Baretton GB, Lock S, Thames HD, Krause M, Baumann M, DKTK-ROG (2014) HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 113:317–323PubMedCrossRef Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rodel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, von Neubeck C, Baretton GB, Lock S, Thames HD, Krause M, Baumann M, DKTK-ROG (2014) HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 113:317–323PubMedCrossRef
15.
Zurück zum Zitat Bersani C, Mints M, Tertipis N, Haeggblom L, Sivars L, Ahrlund-Richter A, Vlastos A, Smedberg C, Grun N, Munck-Wikland E, Nasman A, Ramqvist T, Dalianis T (2017) A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer. Oral Oncol 68:53–59PubMedCrossRef Bersani C, Mints M, Tertipis N, Haeggblom L, Sivars L, Ahrlund-Richter A, Vlastos A, Smedberg C, Grun N, Munck-Wikland E, Nasman A, Ramqvist T, Dalianis T (2017) A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer. Oral Oncol 68:53–59PubMedCrossRef
16.
Zurück zum Zitat Balermpas P, Rodel F, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Sak A, Stuschke M, Gkika E, Grosu AL, Abdollahi A, Debus J, Stangl S, Ganswindt U, Belka C, Pigorsch S, Multhoff G, Combs SE, Welz S, Zips D, Lim SY, Rodel C, Fokas E, DKTK-ROG (2017) The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG). Int J Cancer 141:594–603PubMedCrossRef Balermpas P, Rodel F, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Sak A, Stuschke M, Gkika E, Grosu AL, Abdollahi A, Debus J, Stangl S, Ganswindt U, Belka C, Pigorsch S, Multhoff G, Combs SE, Welz S, Zips D, Lim SY, Rodel C, Fokas E, DKTK-ROG (2017) The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG). Int J Cancer 141:594–603PubMedCrossRef
17.
Zurück zum Zitat Cohen EEW, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ, KEYNOTE-040 investigators (2019) Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 393:156–167CrossRefPubMed Cohen EEW, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ, KEYNOTE-040 investigators (2019) Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 393:156–167CrossRefPubMed
18.
Zurück zum Zitat Tinhofer I, Stenzinger A, Eder T, Konschak R, Niehr F, Endris V, Distel L, Hautmann MG, Mandic R, Stromberger C, Weichert W, Budach V (2016) Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation. Ann Oncol 27:2262–2268PubMedCrossRef Tinhofer I, Stenzinger A, Eder T, Konschak R, Niehr F, Endris V, Distel L, Hautmann MG, Mandic R, Stromberger C, Weichert W, Budach V (2016) Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation. Ann Oncol 27:2262–2268PubMedCrossRef
19.
Zurück zum Zitat Eder T, Hess AK, Konschak R, Stromberger C, Johrens K, Fleischer V, Hummel M, Balermpas P, von der Grun J, Linge A, Lohaus F, Krause M, Baumann M, Stuschke M, Zips D, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Budach V, Tinhofer I, DKTK-ROG (2019) Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German cancer consortium radiation oncology group. Eur J Cancer 116:67–76PubMedCrossRef Eder T, Hess AK, Konschak R, Stromberger C, Johrens K, Fleischer V, Hummel M, Balermpas P, von der Grun J, Linge A, Lohaus F, Krause M, Baumann M, Stuschke M, Zips D, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Budach V, Tinhofer I, DKTK-ROG (2019) Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German cancer consortium radiation oncology group. Eur J Cancer 116:67–76PubMedCrossRef
20.
Zurück zum Zitat Linge A, Lohaus F, Lock S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jutz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rodel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M, DKTK-ROG (2016) HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 121:364–373PubMedCrossRef Linge A, Lohaus F, Lock S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jutz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rodel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M, DKTK-ROG (2016) HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 121:364–373PubMedCrossRef
21.
Zurück zum Zitat Hess AK, Johrens K, Zakarneh A, Balermpas P, Von Der Grün J, Rodel C, Weichert W, Hummel M, Keilholz U, Budach V, Tinhofer I (2019) Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas. OncoImmunology 8:1614858PubMedPubMedCentralCrossRef Hess AK, Johrens K, Zakarneh A, Balermpas P, Von Der Grün J, Rodel C, Weichert W, Hummel M, Keilholz U, Budach V, Tinhofer I (2019) Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas. OncoImmunology 8:1614858PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Budach V, Tinhofer I (2019) Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol 20:e313–e326PubMedCrossRef Budach V, Tinhofer I (2019) Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol 20:e313–e326PubMedCrossRef
23.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedCrossRef Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedCrossRef
24.
Zurück zum Zitat Leijenaar RT, Carvalho S, Hoebers FJ, Aerts HJ, van Elmpt WJ, Huang SH, Chan B, Waldron JN, O’Sullivan B, Lambin P (2015) External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 54:1423–1429PubMedCrossRef Leijenaar RT, Carvalho S, Hoebers FJ, Aerts HJ, van Elmpt WJ, Huang SH, Chan B, Waldron JN, O’Sullivan B, Lambin P (2015) External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 54:1423–1429PubMedCrossRef
25.
Zurück zum Zitat Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38:285–289PubMedCrossRef Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38:285–289PubMedCrossRef
26.
Zurück zum Zitat Nordsmark M, Overgaard J (2004) Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43:396–403PubMedCrossRef Nordsmark M, Overgaard J (2004) Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43:396–403PubMedCrossRef
27.
Zurück zum Zitat Zschaeck S, Haase R, Abolmaali N, Perrin R, Stutzer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zophel K, Baumann M (2015) Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncol 54:1355–1363PubMedCrossRef Zschaeck S, Haase R, Abolmaali N, Perrin R, Stutzer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zophel K, Baumann M (2015) Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncol 54:1355–1363PubMedCrossRef
28.
Zurück zum Zitat Crispin-Ortuzar M, Apte A, Grkovski M, Oh JH, Lee NY, Schöder H, Humm JL, Deasy JO (2018) Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-fluorodeoxyglucose positron emission tomography radiomics features. Radiother Oncol 127:36–42PubMedCrossRef Crispin-Ortuzar M, Apte A, Grkovski M, Oh JH, Lee NY, Schöder H, Humm JL, Deasy JO (2018) Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-fluorodeoxyglucose positron emission tomography radiomics features. Radiother Oncol 127:36–42PubMedCrossRef
29.
Zurück zum Zitat Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, Thorwarth D, Riess O, Zips D, Schroeder C, Welz S (2019) Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol 195:771–779PubMedCrossRef Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, Thorwarth D, Riess O, Zips D, Schroeder C, Welz S (2019) Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol 195:771–779PubMedCrossRef
30.
Zurück zum Zitat Raja JV, Khan M, Ramachandra VK, Al-Kadi O (2012) Texture analysis of CT images in the characterization of oral cancers involving buccal mucosa. Dentomaxillofac Radiol 41:475–480PubMedPubMedCentralCrossRef Raja JV, Khan M, Ramachandra VK, Al-Kadi O (2012) Texture analysis of CT images in the characterization of oral cancers involving buccal mucosa. Dentomaxillofac Radiol 41:475–480PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L, Nemec SF, Mueller-Mang C, Weber M, Mayerhoefer ME (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379PubMedCrossRef Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L, Nemec SF, Mueller-Mang C, Weber M, Mayerhoefer ME (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379PubMedCrossRef
32.
Zurück zum Zitat Brown AM, Nagala S, McLean MA, Lu Y, Scoffings D, Apte A, Gonen M, Stambuk HE, Shaha AR, Tuttle RM, Deasy JO, Priest AN, Jani P, Shukla-Dave A, Griffiths J (2016) Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med 75:1708–1716PubMedCrossRef Brown AM, Nagala S, McLean MA, Lu Y, Scoffings D, Apte A, Gonen M, Stambuk HE, Shaha AR, Tuttle RM, Deasy JO, Priest AN, Jani P, Shukla-Dave A, Griffiths J (2016) Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med 75:1708–1716PubMedCrossRef
33.
Zurück zum Zitat Park M, Kim J, Choi YS, Lee SK, Koh YW, Kim SH, Choi EC (2016) Application of dynamic contrast-enhanced MRI parameters for differentiating squamous cell carcinoma and malignant lymphoma of the oropharynx. AJR Am J Roentgenol 206:401–407PubMedCrossRef Park M, Kim J, Choi YS, Lee SK, Koh YW, Kim SH, Choi EC (2016) Application of dynamic contrast-enhanced MRI parameters for differentiating squamous cell carcinoma and malignant lymphoma of the oropharynx. AJR Am J Roentgenol 206:401–407PubMedCrossRef
34.
Zurück zum Zitat Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors—is it possible to discriminate between benign and malignant masses in a multicenter trial? Fortschr Röntgenstr 188:195–202 Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors—is it possible to discriminate between benign and malignant masses in a multicenter trial? Fortschr Röntgenstr 188:195–202
35.
Zurück zum Zitat Ramkumar S, Ranjbar S, Ning S, Lal D, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2017) MRI-based texture analysis to differentiate sinonasal squamous cell carcinoma from inverted papilloma. AJNR Am J Neuroradiol 38:1019–1025PubMedCrossRefPubMedCentral Ramkumar S, Ranjbar S, Ning S, Lal D, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2017) MRI-based texture analysis to differentiate sinonasal squamous cell carcinoma from inverted papilloma. AJNR Am J Neuroradiol 38:1019–1025PubMedCrossRefPubMedCentral
36.
Zurück zum Zitat Yu H, Caldwell C, Mah K, Mozeg D (2009) Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging 28:374–383PubMedCrossRef Yu H, Caldwell C, Mah K, Mozeg D (2009) Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging 28:374–383PubMedCrossRef
37.
Zurück zum Zitat Yu H, Caldwell C, Mah K, Poon I, Balogh J, MacKenzie R, Khaouam N, Tirona R (2009) Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys 75:618–625PubMedCrossRef Yu H, Caldwell C, Mah K, Poon I, Balogh J, MacKenzie R, Khaouam N, Tirona R (2009) Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys 75:618–625PubMedCrossRef
38.
Zurück zum Zitat Wu B, Khong P‑L, Chan T (2012) Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine. Int J Comput Assist Radiol Surg 7:635–646PubMedCrossRef Wu B, Khong P‑L, Chan T (2012) Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine. Int J Comput Assist Radiol Surg 7:635–646PubMedCrossRef
39.
Zurück zum Zitat Parmar C, Leijenaar RTH, Grossmann P, Rios Velazquez E, Bussink J, Rietveld D, Rietbergen MM, Haibe-Kains B, Lambin P, Aerts HJWL (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044–11044PubMedPubMedCentralCrossRef Parmar C, Leijenaar RTH, Grossmann P, Rios Velazquez E, Bussink J, Rietveld D, Rietbergen MM, Haibe-Kains B, Lambin P, Aerts HJWL (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044–11044PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Ren J, Tian J, Yuan Y, Dong D, Li X, Shi Y, Tao X (2018) Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I–II and III–IV head and neck squamous cell carcinoma. Eur J Radiol 106:1–6PubMedCrossRef Ren J, Tian J, Yuan Y, Dong D, Li X, Shi Y, Tao X (2018) Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I–II and III–IV head and neck squamous cell carcinoma. Eur J Radiol 106:1–6PubMedCrossRef
41.
Zurück zum Zitat Liao KY‑K, Chiu C‑C, Chiang W‑C, Chiou Y‑R, Zhang G, Yang S‑N, Huang T‑C (2019) Radiomics features analysis of PET images in oropharyngeal and hypopharyngeal cancer. Medicine 98:e15446–e15446PubMedPubMedCentralCrossRef Liao KY‑K, Chiu C‑C, Chiang W‑C, Chiou Y‑R, Zhang G, Yang S‑N, Huang T‑C (2019) Radiomics features analysis of PET images in oropharyngeal and hypopharyngeal cancer. Medicine 98:e15446–e15446PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Buch K, Fujita A, Li B, Kawashima Y, Qureshi MM, Sakai O (2015) Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am J Neuroradiol 36:1343–1348PubMedCrossRefPubMedCentral Buch K, Fujita A, Li B, Kawashima Y, Qureshi MM, Sakai O (2015) Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am J Neuroradiol 36:1343–1348PubMedCrossRefPubMedCentral
43.
Zurück zum Zitat Fujita A, Buch K, Li B, Kawashima Y, Qureshi MM, Sakai O (2016) Difference between HPV-positive and HPV-negative non-oropharyngeal head and neck cancer: texture analysis features on CT. J Comput Assist Tomogr 40:43–47PubMedCrossRef Fujita A, Buch K, Li B, Kawashima Y, Qureshi MM, Sakai O (2016) Difference between HPV-positive and HPV-negative non-oropharyngeal head and neck cancer: texture analysis features on CT. J Comput Assist Tomogr 40:43–47PubMedCrossRef
44.
Zurück zum Zitat Bogowicz M, Riesterer O, Ikenberg K, Stieb S, Moch H, Studer G, Guckenberger M, Tanadini-Lang S (2017) Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 99:921–928PubMedCrossRef Bogowicz M, Riesterer O, Ikenberg K, Stieb S, Moch H, Studer G, Guckenberger M, Tanadini-Lang S (2017) Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 99:921–928PubMedCrossRef
45.
Zurück zum Zitat Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O’Sullivan B, Rietveld D (2018) Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. Br J Radiol 91:20170498PubMedPubMedCentralCrossRef Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O’Sullivan B, Rietveld D (2018) Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. Br J Radiol 91:20170498PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Ranjbar S, Ning S, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2018) Computed tomography-based texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinoma. J Comput Assist Tomogr 42:299–305PubMedCrossRef Ranjbar S, Ning S, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2018) Computed tomography-based texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinoma. J Comput Assist Tomogr 42:299–305PubMedCrossRef
47.
Zurück zum Zitat Huang C, Cintra M, Brennan K, Zhou M, Colevas AD, Fischbein N, Zhu S, Gevaert O (2019) Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes. EBioMedicine 45:70–80PubMedPubMedCentralCrossRef Huang C, Cintra M, Brennan K, Zhou M, Colevas AD, Fischbein N, Zhu S, Gevaert O (2019) Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes. EBioMedicine 45:70–80PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD (2019) Imaging-genomic study of head and neck squamous cell carcinoma: associations between radiomic phenotypes and genomic mechanisms via integration of the cancer genome atlas and the cancer imaging archive. JCO Clin Cancer Inform 3:1–9PubMedCrossRef Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD (2019) Imaging-genomic study of head and neck squamous cell carcinoma: associations between radiomic phenotypes and genomic mechanisms via integration of the cancer genome atlas and the cancer imaging archive. JCO Clin Cancer Inform 3:1–9PubMedCrossRef
49.
Zurück zum Zitat Chen R‑Y, Lin Y‑C, Shen W‑C, Hsieh T‑C, Yen K‑Y, Chen S‑W, Kao C‑H (2018) Associations of tumor PD‑1 ligands, immunohistochemical studies, and textural features in (18)F-FDG PET in squamous cell carcinoma of the head and neck. Sci Rep 8:105–105PubMedPubMedCentralCrossRef Chen R‑Y, Lin Y‑C, Shen W‑C, Hsieh T‑C, Yen K‑Y, Chen S‑W, Kao C‑H (2018) Associations of tumor PD‑1 ligands, immunohistochemical studies, and textural features in (18)F-FDG PET in squamous cell carcinoma of the head and neck. Sci Rep 8:105–105PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Meyer H‑J, Schob S, Höhn AK, Surov A (2017) MRI texture analysis reflects histopathology parameters in thyroid cancer—a first preliminary study. Transl Oncol 10:911–916PubMedPubMedCentralCrossRef Meyer H‑J, Schob S, Höhn AK, Surov A (2017) MRI texture analysis reflects histopathology parameters in thyroid cancer—a first preliminary study. Transl Oncol 10:911–916PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Dang M, Lysack JT, Wu T, Matthews TW, Chandarana SP, Brockton NT, Bose P, Bansal G, Cheng H, Mitchell JR, Dort JC (2015) MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 36:166–170PubMedCrossRefPubMedCentral Dang M, Lysack JT, Wu T, Matthews TW, Chandarana SP, Brockton NT, Bose P, Bansal G, Cheng H, Mitchell JR, Dort JC (2015) MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 36:166–170PubMedCrossRefPubMedCentral
52.
Zurück zum Zitat Ulrich EJ, Menda Y, Boles Ponto LL, Anderson CM, Smith BJ, Sunderland JJ, Graham MM, Buatti JM, Beichel RR (2019) FLT PET radiomics for response prediction to chemoradiation therapy in head and neck squamous cell cancer. Tomography 5:161–169PubMedPubMedCentralCrossRef Ulrich EJ, Menda Y, Boles Ponto LL, Anderson CM, Smith BJ, Sunderland JJ, Graham MM, Buatti JM, Beichel RR (2019) FLT PET radiomics for response prediction to chemoradiation therapy in head and neck squamous cell cancer. Tomography 5:161–169PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J (2019) Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT-and PET-imaged head and neck cancer patients. PLoS ONE 14:e222509PubMedPubMedCentralCrossRef Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J (2019) Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT-and PET-imaged head and neck cancer patients. PLoS ONE 14:e222509PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Zhai T‑T, Langendijk JA, van Dijk LV, Halmos GB, Witjes MJ, Oosting SF, Noordzij W, Sijtsema NM, Steenbakkers RJHM (2019) The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-) radiation. Oral Oncol 95:178–186PubMedCrossRef Zhai T‑T, Langendijk JA, van Dijk LV, Halmos GB, Witjes MJ, Oosting SF, Noordzij W, Sijtsema NM, Steenbakkers RJHM (2019) The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-) radiation. Oral Oncol 95:178–186PubMedCrossRef
56.
Zurück zum Zitat Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RT, Garberis I, Gorphe P, Bidault F, Ferté C (2017) Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to human papillomavirus status. Oral Oncol 71:150–155PubMedCrossRef Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RT, Garberis I, Gorphe P, Bidault F, Ferté C (2017) Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to human papillomavirus status. Oral Oncol 71:150–155PubMedCrossRef
57.
Zurück zum Zitat Beaumont J, Acosta O, Devillers A, Palard-Novello X, Chajon E, de Crevoisier R, Castelli J (2019) Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers. EJNMMI Res 9:90PubMedPubMedCentralCrossRef Beaumont J, Acosta O, Devillers A, Palard-Novello X, Chajon E, de Crevoisier R, Castelli J (2019) Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers. EJNMMI Res 9:90PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Diamant A, Chatterjee A, Vallières M, Shenouda G, Seuntjens J (2019) Deep learning in head & neck cancer outcome prediction. Sci Rep 9:2764PubMedPubMedCentralCrossRef Diamant A, Chatterjee A, Vallières M, Shenouda G, Seuntjens J (2019) Deep learning in head & neck cancer outcome prediction. Sci Rep 9:2764PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Cozzi L, Franzese C, Fogliata A, Franceschini D, Navarria P, Tomatis S, Scorsetti M (2019) Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics. Strahlenther Onkol 195:1–14CrossRef Cozzi L, Franzese C, Fogliata A, Franceschini D, Navarria P, Tomatis S, Scorsetti M (2019) Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics. Strahlenther Onkol 195:1–14CrossRef
62.
Zurück zum Zitat Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP (2019) Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma. Eur J Radiol 110:1–6PubMedCrossRef Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP (2019) Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma. Eur J Radiol 110:1–6PubMedCrossRef
64.
Zurück zum Zitat Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V (2017) A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 7:13206PubMedPubMedCentralCrossRef Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V (2017) A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 7:13206PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Vallières M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts HJ, Khaouam N, Nguyen-Tan PF, Wang C‑S, Sultanem K (2017) Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep 7:10117PubMedPubMedCentralCrossRef Vallières M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts HJ, Khaouam N, Nguyen-Tan PF, Wang C‑S, Sultanem K (2017) Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep 7:10117PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T, Sunderland JJ, Graham MM, Buatti JM (2019) FDG PET based prediction of response in head and neck cancer treatment: assessment of new quantitative imaging features. PLoS ONE 14:e215465PubMedPubMedCentralCrossRef Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T, Sunderland JJ, Graham MM, Buatti JM (2019) FDG PET based prediction of response in head and neck cancer treatment: assessment of new quantitative imaging features. PLoS ONE 14:e215465PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Bogowicz M, Riesterer O, Stark LS, Studer G, Unkelbach J, Guckenberger M, Tanadini-Lang S (2017) Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncol 56:1531–1536PubMedCrossRef Bogowicz M, Riesterer O, Stark LS, Studer G, Unkelbach J, Guckenberger M, Tanadini-Lang S (2017) Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncol 56:1531–1536PubMedCrossRef
68.
Zurück zum Zitat Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, Unkelbach J, Guckenberger M, Konukoglu E, Lambin P (2017) Post-radiochemotherapy PET radiomics in head and neck cancer—the influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol 125:385–391PubMedCrossRef Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, Unkelbach J, Guckenberger M, Konukoglu E, Lambin P (2017) Post-radiochemotherapy PET radiomics in head and neck cancer—the influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol 125:385–391PubMedCrossRef
69.
Zurück zum Zitat Liu Y, Shi H, Huang S, Chen X, Zhou H, Chang H, Xia Y, Wang G, Yang X (2019) Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images. Quant Imaging Med Surg 9:1288PubMedPubMedCentralCrossRef Liu Y, Shi H, Huang S, Chen X, Zhou H, Chang H, Xia Y, Wang G, Yang X (2019) Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images. Quant Imaging Med Surg 9:1288PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Sheikh K, Lee SH, Cheng Z, Lakshminarayanan P, Peng L, Han P, McNutt TR, Quon H, Lee J (2019) Predicting acute radiation induced xerostomia in head and neck cancer using MR and CT Radiomics of parotid and submandibular glands. Radiat Oncol 14:131PubMedPubMedCentralCrossRef Sheikh K, Lee SH, Cheng Z, Lakshminarayanan P, Peng L, Han P, McNutt TR, Quon H, Lee J (2019) Predicting acute radiation induced xerostomia in head and neck cancer using MR and CT Radiomics of parotid and submandibular glands. Radiat Oncol 14:131PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Gabryś HS, Buettner F, Sterzing F, Hauswald H, Bangert M (2018) Design and selection of machine learning methods using radiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front Oncol 8:35PubMedPubMedCentralCrossRef Gabryś HS, Buettner F, Sterzing F, Hauswald H, Bangert M (2018) Design and selection of machine learning methods using radiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front Oncol 8:35PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Pota M, Scalco E, Sanguineti G, Farneti A, Cattaneo GM, Rizzo G, Esposito M (2017) Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification. Artif Intell Med 81:41–53PubMedCrossRef Pota M, Scalco E, Sanguineti G, Farneti A, Cattaneo GM, Rizzo G, Esposito M (2017) Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification. Artif Intell Med 81:41–53PubMedCrossRef
73.
Zurück zum Zitat van Dijk LV, Thor M, Steenbakkers RJ, Apte A, Zhai T‑T, Borra R, Noordzij W, Estilo C, Lee N, Langendijk JA (2018) Parotid gland fat related magnetic resonance image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 128:459–466PubMedPubMedCentralCrossRef van Dijk LV, Thor M, Steenbakkers RJ, Apte A, Zhai T‑T, Borra R, Noordzij W, Estilo C, Lee N, Langendijk JA (2018) Parotid gland fat related magnetic resonance image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 128:459–466PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat van Dijk LV, Noordzij W, Brouwer CL, Boellaard R, Burgerhof JG, Langendijk JA, Sijtsema NM, Steenbakkers RJHM (2018) 18F‑FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 126:89–95PubMedCrossRef van Dijk LV, Noordzij W, Brouwer CL, Boellaard R, Burgerhof JG, Langendijk JA, Sijtsema NM, Steenbakkers RJHM (2018) 18F‑FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 126:89–95PubMedCrossRef
75.
Zurück zum Zitat Cheng Z, Nakatsugawa M, Zhou XC, Hu C, Greco S, Kiess A, Page B, Alcorn S, Haller J, Utsunomiya K (2019) Utility of a clinical decision support system in weight loss prediction after head and neck cancer radiotherapy. JCO Clin Cancer Inform 3:1–11PubMed Cheng Z, Nakatsugawa M, Zhou XC, Hu C, Greco S, Kiess A, Page B, Alcorn S, Haller J, Utsunomiya K (2019) Utility of a clinical decision support system in weight loss prediction after head and neck cancer radiotherapy. JCO Clin Cancer Inform 3:1–11PubMed
76.
Zurück zum Zitat Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Mahdavi SR, Kazemnejad A (2018) Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study. Phys Med 45:192–197PubMedCrossRef Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Mahdavi SR, Kazemnejad A (2018) Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study. Phys Med 45:192–197PubMedCrossRef
77.
Zurück zum Zitat Thor M, Tyagi N, Hatzoglou V, Apte A, Saleh Z, Riaz N, Lee NY, Deasy JO (2017) A magnetic resonance imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer. Phys Imaging Radiat Oncol 1:34–40PubMedCrossRef Thor M, Tyagi N, Hatzoglou V, Apte A, Saleh Z, Riaz N, Lee NY, Deasy JO (2017) A magnetic resonance imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer. Phys Imaging Radiat Oncol 1:34–40PubMedCrossRef
78.
Zurück zum Zitat He L, Huang Y, Ma Z, Liang C, Liang C, Liu Z (2016) Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep 6:34921PubMedPubMedCentralCrossRef He L, Huang Y, Ma Z, Liang C, Liang C, Liu Z (2016) Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep 6:34921PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H (2018) Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph 69:134–139PubMedPubMedCentralCrossRef Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H (2018) Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph 69:134–139PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Wei L, Rosen B, Vallières M, Chotchutipan T, Mierzwa M, Eisbruch A, El Naqa I (2019) Automatic recognition and analysis of metal streak artifacts in head and neck computed tomography for radiomics modeling. Phys Imaging Radiat Oncol 10:49–54CrossRefPubMedPubMedCentral Wei L, Rosen B, Vallières M, Chotchutipan T, Mierzwa M, Eisbruch A, El Naqa I (2019) Automatic recognition and analysis of metal streak artifacts in head and neck computed tomography for radiomics modeling. Phys Imaging Radiat Oncol 10:49–54CrossRefPubMedPubMedCentral
81.
Zurück zum Zitat Feldhaus F, Böning G, Jonczyk M, Kahn J, Fehrenbach U, Maurer M, Renz D, Hamm B, Streitparth F (2019) Metallic dental artifact reduction in computed tomography (smart MAR): improvement of image quality and diagnostic confidence in patients with suspected head and neck pathology and oral implants. Eur J Radiol 118:153–160PubMedCrossRef Feldhaus F, Böning G, Jonczyk M, Kahn J, Fehrenbach U, Maurer M, Renz D, Hamm B, Streitparth F (2019) Metallic dental artifact reduction in computed tomography (smart MAR): improvement of image quality and diagnostic confidence in patients with suspected head and neck pathology and oral implants. Eur J Radiol 118:153–160PubMedCrossRef
82.
Zurück zum Zitat Hagen M, Kretschmer M, Würschmidt F, Gauer T, Giro C, Karsten E, Lorenzen J (2019) Clinical relevance of metal artefact reduction in computed tomography (iMAR) in the pelvic and head and neck region: multi-institutional contouring study of gross tumour volumes and organs at risk on clinical cases. J Med Imaging Radiat Oncol. https://doi.org/10.1111/1754-9485.12924CrossRefPubMed Hagen M, Kretschmer M, Würschmidt F, Gauer T, Giro C, Karsten E, Lorenzen J (2019) Clinical relevance of metal artefact reduction in computed tomography (iMAR) in the pelvic and head and neck region: multi-institutional contouring study of gross tumour volumes and organs at risk on clinical cases. J Med Imaging Radiat Oncol. https://​doi.​org/​10.​1111/​1754-9485.​12924CrossRefPubMed
83.
Zurück zum Zitat Hilgenfeld T, Prager M, Schwindling F, Nittka M, Rammelsberg P, Bendszus M, Heiland S, Juerchott A (2018) MSVAT-SPACE-STIR and SEMAC-STIR for reduction of metallic artifacts in 3T head and neck MRI. AJNR Am J Neuroradiol 39:1322–1329PubMedCrossRefPubMedCentral Hilgenfeld T, Prager M, Schwindling F, Nittka M, Rammelsberg P, Bendszus M, Heiland S, Juerchott A (2018) MSVAT-SPACE-STIR and SEMAC-STIR for reduction of metallic artifacts in 3T head and neck MRI. AJNR Am J Neuroradiol 39:1322–1329PubMedCrossRefPubMedCentral
84.
Zurück zum Zitat Pavic M, Bogowicz M, Wurms X, Glatz S, Finazzi T, Riesterer O, Roesch J, Rudofsky L, Friess M, Veit-Haibach P, Huellner M, Opitz I, Weder W, Frauenfelder T, Guckenberger M, Tanadini-Lang S (2018) Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol 57:1070–1074CrossRefPubMed Pavic M, Bogowicz M, Wurms X, Glatz S, Finazzi T, Riesterer O, Roesch J, Rudofsky L, Friess M, Veit-Haibach P, Huellner M, Opitz I, Weder W, Frauenfelder T, Guckenberger M, Tanadini-Lang S (2018) Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol 57:1070–1074CrossRefPubMed
85.
Zurück zum Zitat Hatt M, Laurent B, Fayad H, Jaouen V, Visvikis D, Le Rest CC (2018) Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method. Eur J Nucl Med Mol Imaging 45:630–641PubMedCrossRef Hatt M, Laurent B, Fayad H, Jaouen V, Visvikis D, Le Rest CC (2018) Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method. Eur J Nucl Med Mol Imaging 45:630–641PubMedCrossRef
86.
Zurück zum Zitat Mohamed AS, Hansen C, Weygand J, Ding Y, Frank SJ, Rosenthal DI, Hwang K‑P, Hazle JD, Fuller CD, Wang J (2017) Prospective analysis of in vivo landmark point-based MRI geometric distortion in head and neck cancer patients scanned in immobilized radiation treatment position: results of a prospective quality assurance protocol. Clin Transl Radiat Oncol 7:13–19CrossRef Mohamed AS, Hansen C, Weygand J, Ding Y, Frank SJ, Rosenthal DI, Hwang K‑P, Hazle JD, Fuller CD, Wang J (2017) Prospective analysis of in vivo landmark point-based MRI geometric distortion in head and neck cancer patients scanned in immobilized radiation treatment position: results of a prospective quality assurance protocol. Clin Transl Radiat Oncol 7:13–19CrossRef
87.
Zurück zum Zitat Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O’Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, Gazzani SE, Calareso G, Scheckenbach K, Hoebers F, Wesseling FWR, Keek S, Sanduleanu S, Leijenaar RTH, Vergeer MR, Leemans CR, Terhaard CHJ, van den Brekel MWM, Hamming-Vrieze O, van der Heijden MA, Elhalawani HM, Fuller CD, Guckenberger M, Lambin P (2020) Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Sci Rep 10:4542PubMedPubMedCentralCrossRef Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O’Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, Gazzani SE, Calareso G, Scheckenbach K, Hoebers F, Wesseling FWR, Keek S, Sanduleanu S, Leijenaar RTH, Vergeer MR, Leemans CR, Terhaard CHJ, van den Brekel MWM, Hamming-Vrieze O, van der Heijden MA, Elhalawani HM, Fuller CD, Guckenberger M, Lambin P (2020) Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Sci Rep 10:4542PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat O’Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14:169–186PubMedCrossRef O’Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14:169–186PubMedCrossRef
Metadaten
Titel
Radiomic biomarkers for head and neck squamous cell carcinoma
verfasst von
Stephanie Tanadini-Lang
Panagiotis Balermpas
Matthias Guckenberger
Matea Pavic
Oliver Riesterer
Diem Vuong
Marta Bogowicz
Publikationsdatum
03.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 10/2020
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-020-01638-4

Weitere Artikel der Ausgabe 10/2020

Strahlentherapie und Onkologie 10/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.